These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia. Piljić Burazer M; Mladinov S; Ćapkun V; Kuret S; Glavina Durdov M Med Sci Monit; 2017 Jan; 23():489-497. PubMed ID: 28128193 [TBL] [Abstract][Full Text] [Related]
3. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468 [TBL] [Abstract][Full Text] [Related]
5. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2. McCluggage WG; Shah R; Connolly LE; McBride HA Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis of lymph node micrometastasis at the pN₀ stage of lung adenocarcinoma using a combination of markers. Liu H; Ye YK; Li GM; Zhou Y; Han KB; Xu G; Wang D Genet Mol Res; 2014 Jul; 13(3):5594-600. PubMed ID: 25117316 [TBL] [Abstract][Full Text] [Related]
7. Serrated pathway adenocarcinomas: molecular and immunohistochemical insights into their recognition. Gurzu S; Szentirmay Z; Toth E; Bara T; Bara T; Jung I PLoS One; 2013; 8(3):e57699. PubMed ID: 23469219 [TBL] [Abstract][Full Text] [Related]
8. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma. Su YC; Hsu YC; Chai CY Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563 [TBL] [Abstract][Full Text] [Related]
9. Thyroid Transcription Factor-1 Expression in Adenocarcinomas of the Bile Duct. Lino-Silva LS; Salcedo-Hernández RA; García-Gómez MA; Ruiz-García EB; Aguilar-Romero JM; Domínguez-Rodríguez JA; Herrera-Gómez Á; Maldonado-Martínez HA Int J Surg Pathol; 2016 Feb; 24(1):24-8. PubMed ID: 26316052 [TBL] [Abstract][Full Text] [Related]
10. Comparative Characteristics of Napsin A, TTF 1 and EGFR Mutation Expression in Mucinous Lung Cell Carcinomas. Genova SN; Belovezhdov VT; Bichev SN; Danev VH Folia Med (Plovdiv); 2017 Jun; 59(2):174-182. PubMed ID: 28704186 [TBL] [Abstract][Full Text] [Related]
11. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652 [TBL] [Abstract][Full Text] [Related]
12. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas. Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392 [TBL] [Abstract][Full Text] [Related]
13. Utility of TTF-1 and Napsin-A in the work-up of malignant effusions. El Hag M; Schmidt L; Roh M; Michael CW Diagn Cytopathol; 2016 Apr; 44(4):299-304. PubMed ID: 26799356 [TBL] [Abstract][Full Text] [Related]
14. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms. Chan ES; Alexander J; Swanson PE; Jain D; Yeh MM Am J Surg Pathol; 2012 May; 36(5):737-43. PubMed ID: 22498824 [TBL] [Abstract][Full Text] [Related]
15. Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases. Wang CX; Liu B; Wang YF; Zhang RS; Yu B; Lu ZF; Shi QL; Zhou XJ Int J Clin Exp Pathol; 2014; 7(3):1266-74. PubMed ID: 24696747 [TBL] [Abstract][Full Text] [Related]
16. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung]. Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693 [TBL] [Abstract][Full Text] [Related]
17. Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas. Rossi G; Cavazza A; Righi L; Sartori G; Bisagni A; Longo L; Pelosi G; Papotti M Int J Surg Pathol; 2014 Aug; 22(5):401-7. PubMed ID: 24651909 [TBL] [Abstract][Full Text] [Related]
18. TTF-1 and napsin A do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas: proposal of a novel staining panel. Aulakh KS; Chisholm CD; Smith DA; Speights VO Arch Pathol Lab Med; 2013 Aug; 137(8):1094-8. PubMed ID: 23899066 [TBL] [Abstract][Full Text] [Related]
19. Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung. Lee JG; Kim S; Shim HS Lung Cancer; 2012 Jul; 77(1):156-61. PubMed ID: 22418245 [TBL] [Abstract][Full Text] [Related]
20. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung. Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]